Literature DB >> 7713757

Detection of human papillomavirus in cervical scrapings by in situ hybridization and the polymerase chain reaction in relation to cytology.

M Ramael1, K Segers, N Pannemans, F Wesling, E Van Marck.   

Abstract

A gynaecological out-patient population consisting of 200 patients aged 19-43 years (mean age 34.2 years) was screened for the presence of human papillomavirus (HPV) by the polymerase chain reaction and in situ hybridization on cervical scrapings. A novel method was applied for the detection of HPV in cervical cells by embedding them in a paraffin block before in situ hybridization was performed. This technique resulted in well preserved cytological morphology, easy performance and economy of probes. In eight of the 200 patients (4%), human papillomavirus DNA was revealed by the polymerase chain reaction. Subtyping revealed the presence of HPV serotype 16 DNA in three of these patients. In one patient HPV serotype 18 DNA was also present. The in situ hybridization assay was able to detect all those cases with a specific HPV serotype infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713757     DOI: 10.1007/bf00164172

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  22 in total

Review 1.  Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer. Review article.

Authors:  K J Syrjänen
Journal:  APMIS       Date:  1989-11       Impact factor: 3.205

2.  The association between human papillomavirus deoxyribonucleic acid status and the results of cytologic rescreening tests in young, sexually active women.

Authors:  A B Moscicki; J M Palefsky; J Gonzales; G K Schoolnik
Journal:  Am J Obstet Gynecol       Date:  1991-07       Impact factor: 8.661

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Cytomegalovirus detection by nonisotopic in situ DNA hybridization and viral antigen immunostaining using a two-color technique.

Authors:  R A Wolber; R V Lloyd
Journal:  Hum Pathol       Date:  1988-06       Impact factor: 3.466

5.  Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes.

Authors:  N C Popescu; J A DiPaolo; S C Amsbaugh
Journal:  Cytogenet Cell Genet       Date:  1987

6.  Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.

Authors:  A J van den Brule; C J Meijer; V Bakels; P Kenemans; J M Walboomers
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Comparison of nucleic acid hybridization and cytologic examination for detection of human papillomavirus infection, with evaluation of two commercially available hybridization kits.

Authors:  J A Chimera; S M Anderson; H Noell; V Rizk
Journal:  Clin Chem       Date:  1991-02       Impact factor: 8.327

8.  A comparison study of human papillomavirus prevalence by the polymerase chain reaction in low risk women and in a gynaecology referral group at elevated risk for cervical cancer.

Authors:  M D Goldsborough; P McAllister; R Reid; G Temple; A T Lorincz
Journal:  Mol Cell Probes       Date:  1992-12       Impact factor: 2.365

9.  Detection of human papillomavirus 16 and 18 DNA in epithelial lesions of the lower genital tract by in situ hybridization and polymerase chain reaction: cervical scrapes are not substitutes for biopsies.

Authors:  N Margall; X Matias-Guiu; M Chillon; P Coll; M Alejo; V Nunes; M Quilez; N Rabella; G Prats; J Prat
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes.

Authors:  S Syrjänen; P Partanen; R Mäntyjärvi; K Syrjänen
Journal:  J Virol Methods       Date:  1988 Mar-Apr       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.